• Study Establishes ENPP1 As A Biomarker For Immunotherapy Benefit

    Bio-IT World | Researchers in California have shown that breast cancer patients with RNA expression levels of ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) in the bottom 50th percentile can confidently be treated with Keytruda (pembrolizumab) as well as surgery. Their cancer would have a zero percent chance of metastasizing in seven years.

    Feb 14, 2024

  • Novel NGS-Based Assay Has Seemingly Limitless Virus Detection Potential

    Bio-IT World | Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection.

    Feb 13, 2024

  • GenAI’s Real Potential in Biopharma: As a Cross-Function R&D Assistant

    Bio-IT World | In biopharma R&D there is growing momentum around the use of Generative AI, the deep-learning algorithms capable of distilling complex knowledge into easily digestible summaries. But so far companies have been relatively modest in their ambitions for the technology.

    Feb 9, 2024